PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 115 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $20,000 | -9.1% | 1,890 | +11.6% | 0.00% | 0.0% |
Q2 2019 | $22,000 | -66.7% | 1,694 | -0.6% | 0.00% | -86.7% |
Q1 2019 | $66,000 | +106.2% | 1,705 | +8.6% | 0.02% | +87.5% |
Q4 2018 | $32,000 | -51.5% | 1,570 | +8.3% | 0.01% | -38.5% |
Q3 2018 | $66,000 | -16.5% | 1,450 | +8.6% | 0.01% | -18.8% |
Q2 2018 | $79,000 | -86.9% | 1,335 | -47.5% | 0.02% | -68.0% |
Q1 2015 | $601,000 | +67.9% | 2,544 | +34.7% | 0.05% | +66.7% |
Q4 2014 | $358,000 | -12.5% | 1,888 | +10.0% | 0.03% | -9.1% |
Q3 2014 | $409,000 | +101.5% | 1,717 | -44.3% | 0.03% | +106.2% |
Q2 2014 | $203,000 | -73.8% | 3,082 | -58.5% | 0.02% | -71.4% |
Q1 2014 | $774,000 | +46.6% | 7,427 | +45.6% | 0.06% | +36.6% |
Q4 2013 | $528,000 | – | 5,100 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |